Maxcyte (MXCT) Net Margin (2020 - 2026)

Maxcyte (MXCT) reported Net Margin of 49.22% for Q1 2026, up 12945.0% year-over-year from N/an in Q1 2025, and down 124.46% quarter-over-quarter from 201.22% in Q4 2025.

Maxcyte (MXCT) Net Margin (2020 - 2026) Analysis & Trends

Maxcyte (MXCT) has 7 years of Net Margin data on file, last reported at 49.22% in Q1 2026.

  • Net Margin for Q1 2026 came in at 49.22%, up 12945.0% year-over-year; the trailing twelve-month figure through Mar 2026 was 223.09% (down 7148.0% YoY), and the FY2025 annual result was 212.96%, down 10667.0% from the prior year.
  • Net Margin fell to 49.22% in Q1 2026 per MXCT's latest filing, from 201.22% in the prior quarter.
  • Over five years, Net Margin peaked at 201.22% in Q4 2025 and troughed at 270.72% in Q3 2023.
  • A 5-year average of 106.83% and a median of 121.9% in 2024 frame the typical range for Net Margin.
  • The sharpest annual moves came in 2023 and 2025: Net Margin slumped 26663 bps in 2023, then jumped 32312 bps in 2025.
  • A 5-year view of Net Margin shows it stood at 155.66% in 2022, then slumped by 171 bps to 110.98% in 2023, then slipped by 10 bps to 121.9% in 2024, then jumped by 265 bps to 201.22% in 2025, then slumped by 124 bps to 49.22% in 2026.
  • Business Quant data shows MXCT's Net Margin at 49.22% in Q1 2026, 201.22% in Q4 2025, and 181.81% in Q3 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Net Margin (Qtr)
1 Abbott Laboratories 154.42 Bn 147.76 Bn 6.27 Bn 9.65%
2 Stryker 118.12 Bn 115.25 Bn 3.81 Bn 12.38%
3 Medtronic 101.72 Bn 93.55 Bn 5.76 Bn 12.75%
4 Boston Scientific 67.19 Bn 65.98 Bn 3.61 Bn 25.77%
5 Edwards Lifesciences 50.69 Bn 47.02 Bn 1.29 Bn -
6 Koninklijke Philips 29.38 Bn 26.07 Bn 2.07 Bn 0.00%
7 Dexcom 28.09 Bn 26.97 Bn 750.30 Mn 16.74%
8 GE HealthCare Technologies 28.08 Bn 26.02 Bn 1.98 Bn 8.01%
9 Steris 19.80 Bn 19.37 Bn 697.10 Mn -
10 Maxcyte 127.72 Mn 127.72 Mn 8.08 Mn -49.22%

Historic Data

Download Data
DateValue
Mar 31, 2026 -49.22%
Dec 31, 2025 201.22%
Sep 30, 2025 -181.81%
Jun 30, 2025 -212.17%
Mar 31, 2025 -178.67%
Dec 31, 2024 -121.90%
Sep 30, 2024 -141.56%
Jun 30, 2024 -188.86%
Mar 31, 2024 -170.59%
Dec 31, 2023 -110.98%
Sep 30, 2023 -270.72%
Jun 30, 2023 -116.24%
Mar 31, 2023 -219.22%
Dec 31, 2022 155.66%
Sep 30, 2022 -89.95%
Jun 30, 2022 -85.97%
Mar 31, 2022 -35.10%
Dec 31, 2021 224.55%
Sep 30, 2021 -47.79%
Jun 30, 2021 -62.21%